Dacomitinib

Vizimpro 45 MG Comprimidos Recubiertos con Pelicula

46.729 mg comprimido recubierto con películaSpainAuthorisedAuthorised 23 May 2019

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

VizimproEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Dacomitinib

Vizimpro 45 MG Comprimidos Recubiertos con Pelicula

46.729 mg comprimido recubierto con películaSpainAuthorisedAuthorised 23 May 2019

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

VizimproEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Vizimpro 15 mg filmomhulde tablettenNetherlands · Filmomhulde tablet · Pfizer Europe MA EEIG

Vizimpro 30 mg filmomhulde tablettenNetherlands · Filmomhulde tablet · Pfizer Europe MA EEIG

Vizimpro 45 mg filmomhulde tablettenNetherlands · Filmomhulde tablet · Pfizer Europe MA EEIG

VizimproSaudi Arabia · Pfizer Manufacturing Deutschland GmbH

Vizimpro Film-Coated Tablet 15MGSingapore · 15 mg · tablet, film coated · Pfizer Private Limited

Vizimpro Film-Coated Tablet 30MGSingapore · 30 mg · tablet, film coated · Pfizer Private Limited

Vizimpro Film-Coated Tablet 45MGSingapore · 45 mg · tablet, film coated · Pfizer Private Limited

VizimproUnited States · 15MG, 30MG, 45MG · tablet · Pfizer

Packs

Pack	Code	Status
VIZIMPRO 45 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos	725349

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Dacomitinib
Strength: 46.729 mg
Dosage form: comprimido recubierto con película
Route: vía oral
Register: Spain (AEMPS)
Status: Authorised
Status in the register: Autorizado, no comercializado
Authorised: 23 May 2019
Registration: 1191354003
Marketing authorisation holder: Pfizer Europe Ma Eeig
Procedure: EU centralised
Supply: Diagnóstico Hospitalario
EU number: EU/1/19/1354

Spain